Probing cocaine-antibody interactions in buffer and human serum

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Ramakrishnan, Muthu ^a,b   de Melo, Fernando Alves ^c   Kinsey, Berma M ^a,b   Ladbury, John E ^c   Kosten, Thomas R ^a,b   Orson, Frank M ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BENZOYLECGONINE; BOVINE SERUM ALBUMIN; COCAINE; HAPTEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SUCCINYL NORCOCAINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CONJUGATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; HUMAN; ISOTHERMAL TITRATION CALORIMETRY; MICROSCALE THERMOPHORESIS; MOUSE; NONHUMAN; SERUM; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY AFFINITY; BINDING, COMPETITIVE; CALORIMETRY; CATTLE; COCAINE; COCAINE-RELATED DISORDERS; HUMANS; IMMOBILIZED PROTEINS; IMMUNOTHERAPY; KINETICS; MICE; PROTEIN BINDING; SERUM; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SURFACE PLASMON RESONANCE;

BOVINAE; MUS;

EID: 84863668596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040518     Document Type: Article

References (28)

1. Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR, (2009) Vaccines for cocaine abuse. Hum Vaccin 5: 194-199.
2. Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, et al. (2008) Substance abuse vaccines. Ann N Y Acad Sci 1141: 257-269.
3. Chi KR, (2011) Vaccines move forward against a range of addictions. Nat Med 17: 146.
4. Kinsey BM, Kosten TR, Orson FM, (2010) Anti-cocaine vaccine development. Expert Rev Vaccines 9: 1109-1114.
5. Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, et al. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2: 1129-1132.
6. Norman AB, Norman MK, Buesing WR, Tabet MR, Tsibulsky VL, et al. (2009) The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats. J Pharmacol Exp Ther 328: 873-881.
7. Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, et al. (2007) A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. J Pharmacol Exp Ther 320: 145-153.
8. Hicks MJ, de BP, Rosenberg JB, Davidson JT, Moreno AY, et al. (2011) Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. Mol Ther 19: 612-619.
9. Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, et al. (2009) Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry 66: 1116-1123.
10. Carrera MR, Ashley JA, Parsons LH, Wirsching P, Koob GF, et al. (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature 378: 727-730.
11. Pardridge WM, (2010) Biopharmaceutical drug targeting to the brain. J Drug Target 18: 157-167.
12. Paula S, Tabet MR, Farr CD, Norman AB, Ball WJ, (2004) Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. J Med Chem 47: 133-142.
13. Paula S, Tabet MR, Keenan SM, Welsh WJ, Ball WJ, (2003) Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis. J Mol Biol 325: 515-530.
14. Meijler MM, Kaufmann GF, Qi L, Mee JM, Coyle AR, et al. (2005) Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies. J Am Chem Soc 127: 2477-2484.
15. Ladbury JE, Klebe G, Freire E, (2010) Adding calorimetric data to decision making in lead discovery: a hot tip. Nat Rev Drug Discov 9: 23-27.
16. Ladbury JE, (2010) Calorimetry as a tool for understanding biomolecular interactions and an aid to drug design. Biochem Soc Trans 38: 888-893.
17. Livingstone JR, (1996) Antibody characterization by isothermal titration calorimetry. Nature 384: 491-492.
18. Jerabek-Willemsen M, Wienken CJ, Braun D, Baaske P, Duhr S, (2011) Molecular interaction studies using microscale thermophoresis. Assay Drug Dev Technol 9: 342-353.
19. Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S, (2010) Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun 1: 100.
20. Everhart ET, Jacob P III, Mendelson J, Jones RT, (1999) The synthesis of deuterium-labelled cocaine, cocaethylene and metabolites. Journal of Labelled Compounds and Radiopharmaceuticals 42: 1265.
21. Hrafnkelsdottir K, Valgeirsson J, Gizurarson S, (2005) Induction of protective and specific antibodies against cocaine by intranasal immunisation using a glyceride adjuvant. Biol Pharm Bull 28: 1038-1042.
22. Ladbury JE, (1995) Counting the calories to stay in the groove. Structure 3: 635-639.
23. Edwards DJ, Bowles SK, (1988) Protein binding of cocaine in human serum. Pharm Res 5: 440-442.
24. Parker RB, Williams CL, Laizure SC, Lima JJ, (1995) Factors affecting serum protein binding of cocaine in humans. J Pharmacol Exp Ther 275: 605-610.
25. Mets B, Diaz J, Soo E, Jamdar S, (1999) Cocaine, norcocaine, ecgonine methylester and benzoylecgonine pharmacokinetics in the rat. Life Sci 65: 1317-1328.
26. Lau CE, Ma F, Foster DM, Falk JL, (1999) Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits. J Pharmacol Exp Ther 288: 535-543.
27. Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ, (2002) Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration. J Anal Toxicol 26: 382-392.
28. Atchley WT, Peterson EC, West CM, Owens SM, (2011) Determining the Biochemical Basis of In Vivo Functional Changes to a Therapeutic Anti-Methamphetamine Monoclonal antibody using a Recombinantly Engineered IgG. National Biotechnology Conference. Hilton Union Square San Francisco, USA.: American Association of Pharmaceutical Science.